CD8A and neoplasm: Consequently, KMT2D-mutant tumors in both mice and humans displayed enhanced immune infiltration, characterized by elevated levels of cytokines like CCL2, CCL5, CCL22, and CXCL9 that attract antigen-presenting cells and CD8+ T cells into the tumor microenvironment.